44
Participants
Start Date
June 13, 2000
Primary Completion Date
January 23, 2003
Study Completion Date
July 20, 2006
temozolomide
thalidomide
Memorial Sloan-Kettering Cancer Center, New York
University of Pittsburgh Cancer Institute, Pittsburgh
Neuro-Oncology Branch, Bethesda
University of Wisconsin Comprehensive Cancer Center, Madison
University of Texas - MD Anderson Cancer Center, Houston
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
UCSF Cancer Center and Cancer Research Institute, San Francisco
Dana-Farber Cancer Institute, Boston
University of Michigan Comprehensive Cancer Center, Ann Arbor
Simmons Cancer Center - Dallas, Dallas
University of Texas Health Science Center at San Antonio, San Antonio
National Cancer Institute (NCI)
NIH
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER